Armand-Ugón M - Search Results

1

The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.

Armand-Ugón M, Clotet-Codina I, Tintori C, Manetti F, Clotet B, Botta M, Esté JA. Armand-Ugón M, et al. Virology. 2005 Dec 5;343(1):141-9. doi: 10.1016/j.virol.2005.08.007. Epub 2005 Sep 15. Virology. 2005. PMID: 16168454 Free article.

2

Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events.

Blanco J, Barretina J, Ferri KF, Jacotot E, Gutiérrez A, Armand-Ugón M, Cabrera C, Kroemer G, Clotet B, Esté JA. Blanco J, et al. Virology. 2003 Jan 20;305(2):318-29. doi: 10.1006/viro.2002.1764. Virology. 2003. PMID: 12573577 Free article.

3

Reduced fitness of HIV-1 resistant to CXCR4 antagonists.

Armand-Ugón M, Quiñones-Mateu ME, Gutiérez A, Barretina J, Blanco J, Schols D, De Clercq E, Clotet B, Esté JA. Armand-Ugón M, et al. Antivir Ther. 2003 Feb;8(1):1-8. Antivir Ther. 2003. PMID: 12713058

4

Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.

Barretina J, Blanco J, Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Barretina J, et al. Antivir Ther. 2003 Apr;8(2):155-61. Antivir Ther. 2003. PMID: 12741628

5

HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.

Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Armand-Ugón M, et al. Antiviral Res. 2003 Jul;59(2):137-42. doi: 10.1016/s0166-3542(03)00071-8. Antiviral Res. 2003. PMID: 12895697

6

A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity.

Manetti F, Tintori C, Armand-Ugón M, Clotet-Codina I, Massa S, Ragno R, Esté JA, Botta M. Manetti F, et al. J Chem Inf Model. 2006 May-Jun;46(3):1344-51. doi: 10.1021/ci050414h. J Chem Inf Model. 2006. PMID: 16711753

7

HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.

Senserrich J, Pauls E, Armand-Ugón M, Clotet-Codina I, Moncunill G, Clotet B, Esté JA. Senserrich J, et al. Virology. 2008 Mar 15;372(2):421-9. doi: 10.1016/j.virol.2007.10.045. Epub 2007 Dec 18. Virology. 2008. PMID: 18068205 Free article.

8

HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.

Moncunill G, Armand-Ugón M, Pauls E, Clotet B, Esté JA. Moncunill G, et al. AIDS. 2008 Jan 2;22(1):23-31. doi: 10.1097/QAD.0b013e3282f303e6. AIDS. 2008. PMID: 18090388

9

Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.

Moncunill G, Armand-Ugón M, Clotet-Codina I, Pauls E, Ballana E, Llano A, Romagnoli B, Vrijbloed JW, Gombert FO, Clotet B, De Marco S, Esté JA. Moncunill G, et al. Mol Pharmacol. 2008 Apr;73(4):1264-73. doi: 10.1124/mol.107.042911. Epub 2008 Jan 8. Mol Pharmacol. 2008. PMID: 18182480

10

Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5.

Armand-Ugón M, Moncunill G, Gonzalez E, Mena M, Ballana E, Clotet B, Esté JA. Armand-Ugón M, et al. J Antimicrob Chemother. 2010 Mar;65(3):417-24. doi: 10.1093/jac/dkp482. Epub 2010 Jan 12. J Antimicrob Chemother. 2010. PMID: 20067983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters